CloseClose
Find a Drug
Advanced Search

Professional

Zemplar Injection

Clinical Pharmacology
font size

Clinical Pharmacology

Zemplar Injection

A long-term, open-label safety study of 164 CKD Stage 5 patients (mean dose of 7.5 mcg three times per week), demonstrated that mean serum Ca, P, and Ca x P remained within clinically appropriate ranges with PTH reduction (mean decrease of 319 pg/mL at 13 months).

REFERENCES

1. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003; Volume 42(4): Supplement 3.

Brand Name: Zemplar Injection
Generic Name: Paricalcitol Injection Fliptop Vial

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.


Bookmark this page:

Privacy Policy

Women's Health

Find out what women really need.

WebMD Symptom Checker - Start Here Ringworm Slideshow: Watch and Learn

Home Dialysis for Kidney FailureHome Dialysis for Kidney Failure
Kidney dialysis for failing kidneys can now be done at home thanks to a new portable machine. See more WebMD Videos »